Skip to main content
Erschienen in: Drug Safety 8/2013

01.08.2013 | Original Research Article

Choosing Thresholds for Statistical Signal Detection with the Proportional Reporting Ratio

verfasst von: Jim Slattery, Yolanda Alvarez, Ana Hidalgo

Erschienen in: Drug Safety | Ausgabe 8/2013

Einloggen, um Zugang zu erhalten

Abstract

Background

Identification of potential drug safety problems using statistical screening algorithms in routinely collected databases of adverse drug reactions (ADRs) requires decision rules based on thresholds of the chosen parameters. Choosing higher or lower thresholds changes both the sensitivity of the screening and the number of false alarms produced, and thus has an impact on the effectiveness of the detection process.

Objective

The aim of this study was to evaluate the impact on the effectiveness of signal detection activities of choosing different warning thresholds for the proportional reporting ratio (PRR) and for the count of reports of any drug-event combination.

Methods

Signal detection methods were tested within the EudraVigilance database of suspected ADRs. Using an established set of known ADRs, the number that could be detected and the changes in time gained for earlier investigation of the signal were calculated over a range of signal detection thresholds. These figures were set against the number of false positive signals produced by the statistical signal detection algorithms.

Results

Higher thresholds for the lower confidence bound of the PRR produced fewer false positives but this benefit was offset by important losses of sensitivity in the detection of ADRs. By contrast, increases in the threshold for the count of a specific drug-event combination produced fewer false positives with little loss of either sensitivity or time gained for investigation of adverse events. A threshold of five compared with the current European Medicines Agency threshold of three gave a reduction of 25 % in false positive signals in return for a loss of 12 % in true signals detected early.

Conclusion

Changes in the standard threshold for the count of drug-event combinations can result in a substantial improvement in efficiency of the signal detection process. Initially this change might be applied only to products with a well-established safety profile.
Fußnoten
1
MedDRA® terminology is the international medical terminology developed under the auspices of the International Conference on Harmonization (ICH) of Technical Requirements for Registration of Pharmaceuticals for Human Use.
 
Literatur
1.
Zurück zum Zitat Finney DJ. Statistical logic in the monitoring of adverse reactions to therapeutic drugs. Methods Inf Med. 1971;10:237–42.PubMed Finney DJ. Statistical logic in the monitoring of adverse reactions to therapeutic drugs. Methods Inf Med. 1971;10:237–42.PubMed
2.
Zurück zum Zitat Alvarez Y, Hidalgo A, Maignen F, Slattery J. Validation of statistical signal detection procedures in EudraVigilance post-authorisation data: a retrospective evaluation of the potential for earlier signalling. Drug Saf. 2010;33(6):475–87.CrossRefPubMed Alvarez Y, Hidalgo A, Maignen F, Slattery J. Validation of statistical signal detection procedures in EudraVigilance post-authorisation data: a retrospective evaluation of the potential for earlier signalling. Drug Saf. 2010;33(6):475–87.CrossRefPubMed
6.
Zurück zum Zitat Evans SJW, Waller P, Davis S. Use of proportional reporting ratios (PRR) for signal generation from spontaneous adverse drug reaction reports. Pharmacoepidemiol Drug Saf. 2001;10:483–6.CrossRefPubMed Evans SJW, Waller P, Davis S. Use of proportional reporting ratios (PRR) for signal generation from spontaneous adverse drug reaction reports. Pharmacoepidemiol Drug Saf. 2001;10:483–6.CrossRefPubMed
9.
Zurück zum Zitat Matsushita Y, Kuroda Y, Niwa S, Sonehara S, Hamada C, Yoshimura I. Criteria revision and performance comparison of three methods of signal detection applied to the spontaneous reporting database of a pharmaceutical manufacturer. Drug Saf. 2007;30(8):715–26.CrossRefPubMed Matsushita Y, Kuroda Y, Niwa S, Sonehara S, Hamada C, Yoshimura I. Criteria revision and performance comparison of three methods of signal detection applied to the spontaneous reporting database of a pharmaceutical manufacturer. Drug Saf. 2007;30(8):715–26.CrossRefPubMed
10.
Zurück zum Zitat Almenoff J, LaCroix K, Yuen N, et al. Comparative performance of two quantitative safety signalling methods. Drug Saf. 2006;29(10):875–87.CrossRefPubMed Almenoff J, LaCroix K, Yuen N, et al. Comparative performance of two quantitative safety signalling methods. Drug Saf. 2006;29(10):875–87.CrossRefPubMed
11.
Zurück zum Zitat Ahmed I, Thiessard F, Miremont-Salame G, et al. Early detection of pharmacovigilance signals with automated methods based on false discovery rates. Drug Saf. 2012;35(6):495–506.CrossRefPubMed Ahmed I, Thiessard F, Miremont-Salame G, et al. Early detection of pharmacovigilance signals with automated methods based on false discovery rates. Drug Saf. 2012;35(6):495–506.CrossRefPubMed
12.
Zurück zum Zitat Berlin C, Blanch C, Lewis D, et al. Are all quantitative postmarketing signal detection methods equal? Performance characteristics of logistic regression and multi-item Gamma Poisson Shrinker. Pharmacoepidemiol Drug Saf. 2012;21:622–30.CrossRefPubMed Berlin C, Blanch C, Lewis D, et al. Are all quantitative postmarketing signal detection methods equal? Performance characteristics of logistic regression and multi-item Gamma Poisson Shrinker. Pharmacoepidemiol Drug Saf. 2012;21:622–30.CrossRefPubMed
Metadaten
Titel
Choosing Thresholds for Statistical Signal Detection with the Proportional Reporting Ratio
verfasst von
Jim Slattery
Yolanda Alvarez
Ana Hidalgo
Publikationsdatum
01.08.2013
Verlag
Springer International Publishing
Erschienen in
Drug Safety / Ausgabe 8/2013
Print ISSN: 0114-5916
Elektronische ISSN: 1179-1942
DOI
https://doi.org/10.1007/s40264-013-0075-1

Weitere Artikel der Ausgabe 8/2013

Drug Safety 8/2013 Zur Ausgabe